XML 26 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2023 $ 11 $ 4,123 $ (6,212) $ (2,078)
Balance, shares at Dec. 31, 2023 10,562,640      
Issuance of common shares upon the closing of the initial public offering, net of offering costs $ 2 4,650   4,652
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares 1,550,000      
Issuance of common shares upon conversion of convertible notes payable and accrued interest 884   884
Issuance of common shares upon conversion of convertible notes payable and accrued interest, shares 368,371      
Issuance of common shares upon conversion of accounts payable 1,789   $ 1,789
Issuance of common shares upon conversion of accounts payable, shares 514,940     514,940
Issuance of common shares upon conversion of amounts due to related parties 7   $ 7
Issuance of common shares upon conversion of amounts due to related parties, shares 1,664      
Issuance of common shares for deferred offering costs $ 1 1,877   1,878
Issuance of common shares for deferred offering costs, shares 670,641      
Fair value of warrants issued in connection with convertible notes payable 29   29
Fair value of vested restricted stock units 218   218
Fair value of vested restricted stock units, shares 68,341      
Net loss (2,603) (2,603)
Balance at Dec. 31, 2024 $ 14 13,577 (8,815) 4,776
Balance, shares at Dec. 31, 2024 13,736,597      
Fair value of vested restricted stock units 482 482
Fair value of vested restricted stock units, shares 144,707      
Net loss (5,447) (5,447)
Proceeds from the sale of common shares and pre-funded warrants, net of offering costs $ 2 3,056 3,058
Proceeds from the sale of common shares and pre-funded warrants, net of offering costs, shares 2,500,000      
Fair value of common shares issued for deferred offering costs 327 327
Fair value of common shares issued for deferred offering costs, shares 384,459      
Common shares issued for cash through equity line of credit, net of expenses $ 4 2,984 2,988
Common shares issued for cash through equity line of credit, net of expenses, shares 3,510,000      
Issuance of common shares recorded as a vendor advance $ 1 156 157
Issuance of common shares recorded as a vendor advance, shares 534,188      
Issuance of common shares through cashless exercise of stock warrants
Issuance of common shares through cashless exercise of stock warrants, shares 11,402      
Balance at Dec. 31, 2025 $ 21 $ 20,582 $ (14,262) $ 6,341
Balance, shares at Dec. 31, 2025 20,821,353